Banaschewski, T, Soutullo, C, Lecendreux, M, Johnson, M, Zuddas, A, Hodgkins, P, Adeyi, B, Squires, LA, Coghill, DR.
EPA-1078 – The child health and illness profile as a measure of health-related quality of life in stimulant-treated children and adolescents with ADHD.
European Psychiatry
29:
1
2014
view publication
Coghill, DR, Banaschewski, T, Lecendreux, M, Soutullo, C, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Dauphin, M, Lyne, A, et al.
EPA-1407 – The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
European Psychiatry
29:
1
2014
view publication
Holden, SE, Jenkins-Jones, S, Poole, CD, Morgan, CL, Coghill, D, Currie, CJ.
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).
Child and Adolescent Psychiatry and Mental Health
7(1)
:
34
2013
view publication
Dittmann, RW, Cardo, E, Nagy, P, Anderson, CS, Bloomfield, R, Caballero, B, Higgins, N, Hodgkins, P, Lyne, A, Civil, R, et al.
Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study.
CNS Drugs
27(12)
:
1081 -1092
2013
view publication
Coghill, D, Banaschewski, T, Zuddas, A, Pelaz, A, Gagliano, A, Doepfner, M.
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies.
BMC Psychiatry
13(1)
:
237
2013
view publication
